Mobius Biomedical: Funding, Investors & Team (Sep 2026)
Mobius Biomedical plans to bring unprecedented efficiencies to the development and manufacturing of biologics and biosimilars, and reduce their cost by over 90% at commercial scale. The Company has developed new design, new process and new equipment to drastically reduce the capex, opex and facility footprint of manufacturing plants while maintaining the purity, throughput and efficiency at commercial scale.
Mobius Biomedical has raised $100k across 1 funding round on record, the most recent an undisclosed round of $100k announced in Mar 2022.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Mobius Biomedical Company Profile and Key Stats
Latest funding round on record: Mar 2022.
Mobius Biomedical Funding Rounds
Mobius Biomedical Founders and Leadership Team
No contact details are on record for this team yet.
Mobius Biomedical Funding Compared to Other Biotechnology Startups
Mobius Biomedical's latest round of $100k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Mobius Biomedical in Biotechnology and Lowell
Companies Similar to Mobius Biomedical
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Mobius Biomedical Funding FAQs
What does Mobius Biomedical do?
Mobius Biomedical plans to bring unprecedented efficiencies to the development and manufacturing of biologics and biosimilars, and reduce their cost by over 90% at commercial scale. The Company has developed new design, new process and new equipment to drastically reduce the capex, opex and facility footprint of manufacturing plants while maintaining the purity, throughput and efficiency at commercial scale.
How much funding has Mobius Biomedical raised?
Mobius Biomedical has raised $100k across 1 round on record. The most recent is an undisclosed round of $100k announced in Mar 2022.
When did Mobius Biomedical last raise funding?
Mobius Biomedical's most recent funding round on record is an undisclosed round of $100k, announced in Mar 2022.
Who is the CEO of Mobius Biomedical?
Vishal Jain is listed as CEO at Mobius Biomedical.
Where is Mobius Biomedical headquartered?
Mobius Biomedical is based in Lowell, Massachusetts, United States.
How many employees does Mobius Biomedical have?
Mobius Biomedical is in the 1-10 employee band.
How does Mobius Biomedical's funding compare to other Biotechnology startups?
Mobius Biomedical's latest round of $100k is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Mobius Biomedical Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Mobius Biomedical is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.